Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Similar documents
Gillette India. Institutional Equities. 1QFY18 Result Update

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Colgate-Palmolive (India)

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Institutional Equities

Jamna Auto Industries

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Indian Oil Corporation

EBITDA 5,076 3, , EBITDA

Dalmia Bharat Enterprises

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Punjab National Bank

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Dabur India. Institutional Equities. 1QFY19 Result Update

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Institutional Equities

Bata India. Institutional Equities. 1QFY19 Result Update BUY

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Indian Oil Corporation

Punjab National Bank

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

EBITDA 6,223 6,511 (4.4) 5, EBITDA

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Institutional Equities

Institutional Equities

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Hindustan Unilever. Institutional Equities. 2QFY19 Result Update

Institutional Equities

Institutional Equities

Institutional Equities

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Institutional Equities

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

Hindustan Unilever. Institutional Equities. 3QFY18 Result Update BUY

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Institutional Equities

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Institutional Equities

Institutional Equities

Institutional Equities

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.

Institutional Equities

3,746 2,551 3, NIM

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

Bharat Financial Inclusion

2,09,057 1,85,859 2,17, (4.1) NIM

18,948 15,784 18, NIM

The Ramco Cements. Institutional Equities. Event Update BUY

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

9,500 7,914 8, NIM

Institutional Equities

Hindustan Unilever. Institutional Equities. Company Update. Faster And Stronger BUY. Sector: FMCG CMP: Rs1,350 Target Price: Rs1,570 Upside: 16%

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Dalmia Bharat Enterprises

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

93,707 77,814 90, NIM

E&P To Stay Strong; Consumer Segment To Revive

Dalmia Bharat Enterprises

Initiating Coverage. Uflex Ltd.

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA

Swiss Glascoat Equipments

Sun Pharmaceutical Industries

Operating expenses tracked lower than core total income growth as ABL displayed continued

La Opala RG. Institutional Equities. 1QFY18 Result Update

V-Guard Industries. Institutional Equities. Conference-call Update BUY. Sector: White Goods CMP: Rs914 Target Price: Rs1,109 Upside: 21%

EBITDA 5,019 4,211 5, EBITDA

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

Punjab National Bank

South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018

Muthoot Finance. Institutional Equities. 1QFY19 Result Update

Institutional Equities

Punjab National Bank

9,251 7,812 8, NIM

Punjab National Bank

Institutional Equities

9,807 8,007 9, NIM

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY

Bata India. Institutional Equities. Management Meet Update. Likely Getting Into A Virtuous Cycle BUY

Transcription:

1QCY18 Result Update Institutional Equities Nestle India 11 May 218 Reuters: NEST.BO; Bloomberg: NEST IN Resurgence Continues Nestle India (NEST) reported strong overall performance during 1QCY18 driven by volume led revenue growth and improved profitability on the back of favourable commodity prices and efficiency measures adopted by the management. Comparable revenue growth in domestic business was 13.4% led by volumes and operating profit grew by 34.7% YoY. Healthy top-line performance was largely in line with our expectations however NEST positively surprised us on profitability front. Volume led double digit revenue growth: Management has delivered on its promise and reported strong volume driven revenue growth of 1.6% YoY on reported basis wherein domestic sales grew by 13.4% on like to like basis (1.9% on reported basis). We believe that NEST s innovation and new launches across the categories has been the turning point. During the quarter, NEST continued to expand its chocolate and confectionary portfolio by launching KitKat Strawberry Duo and Munch Crunch- O-Nuts available at an attractive price points. Recently, NEST announced adding Nestle Breakfast cereals from Cereal Partners Worldwide (CPW) to its portfolio which is a welcome move wherein we believe that NEST is further strengthening its presence in the healthy and nutritious food segments which is a less penetrated however fast growing category in India. We believe that management s continued focus on innovation and new launches across the categories will lead to high single digit to low double digit underlying volume growth in the medium term. Improved profitability: Favourable commodity prices (especially milk and milk solids) and premiumisation across the categories have helped NEST to report 3bps gross margin expansion YoY during the quarter. We believe that moderate input costs will continue to benefit NEST in subsequent quarters as well. With higher scale and focus on cost efficiency, NEST will continue to enjoy benefits of operating leverage. During the quarter, EBITDA grew by 34.7% which was 13.3% higher than our expectations and EBITDA margin stood at 25.3% thereby showing strong 45bps margin expansion on YoY basis. Apart from operational measures, NEST managed to improve its other income on account of higher liquidation and yields during the quarter. However, effective tax rate for the quarter has increased due to end of the income tax holiday at Samalkha factory Unit 2. As a result, Net income of Rs.424mn grew by 38.2% which was 13% above our expectations. Outlook and Valuation: In our opinion, strong and relentless efforts by NEST to achieve high volume growth are credible. Also, its business excellence model emphasises a lot on reduced processes and efficiency which along with increased elbow room for pricing after GST rate cut and favourable commodity basket should be margin accretive. Therefore, we have revised our earnings estimates upwards. We have retained our Buy rating on NEST with a revised target price of Rs.1,7 (earlier Rs.9,4) after rolling forward our investment horizon to June 219, implying an upside of 19% from CMP based on an earnings multiple of 5x. BUY Sector: FMCG CMP: Rs8,981 Target Price: Rs1,7 Upside: 19% Vijay Chugh Research Analyst vijay.chugh@nirmalbang.com +91-22-6273 864 Abhishek Navalgund Research Associate abhishek.navalgund@nirmalbang.com +91-22-6273 813 Key Data Current Shares O/S (mn) 96.4 Mkt Cap (Rsbn/US$bn) 866/12.9 52 Wk H / L (Rs) 9,497/6,45 Daily Vol. (3M NSE Avg.) 81,437 Price Performance 1 M 6 M 1 Yr Nestle India 5.7 15.4 29.8 Nifty Index 3. 3.8 13.9 Source: Bloomberg Particulars (Rsmn) 1QCY17 4QCY17 1QCY18 YoY QoQ CY16 CY17 YoY Net Sales 24,919 26,15 27,572 1.6 6. 91,413 1,,96 9.5 COGS 1,939 1,693 11,277 3.1 5.5 38,828 43,269 11.4 % of sales 43.9 41.1 4.9 (3bps) (2bps) 42.5 43.2 8bps Gross margin % 56.1 58.9 59.1 3bps 2bps 57.5 56.8 8bps Employee costs 2,461 2,67 2,69 9.3 3.2 9,16 1,175 12.9 % of sales 9.9 1. 9.8 (1bps) (3bps) 9.9 1.2 3bps Other expenses 6,345 7,38 6,637 4.6 (1.1) 25,71 25,688 2.5 % of sales 25.5 28.4 24.1 (14bps) (43bps) 27.4 25.7 (18bps) EBITDA 5,174 5,335 6,969 34.7 3.6 18,498 2,965 13.3 EBITDA margin % 2.8 2.5 25.3 45bps 48bps 2.2 2.9 7bps Depreciation 867 838 825 (4.8) (1.5) 3,537 3,423 (3.2) EBIT 4,37 4,497 6,143 42.6 36.6 14,961 17,543 17.3 EBIT margin % 17.3 17.3 22.3 5bps 5bps 16.4 17.5 12bps Interest expense 228 234 311 36.5 32.8 99 919 1.1 Other income 416 511 564 35.8 1.5 1,59 1,769 17.2 Exceptional items - - - - - (18) - - PBT 4,495 4,774 6,397 42.3 34. 15,454 18,393 19. Tax 1,428 1,656 2,157 51. 3.2 5,44 6,141 12.9 Effective tax rate % 31.8 34.7 33.7 2bps (1bps) 35.2 33.4 (18bps) PAT 3,68 3,118 4,24 38.2 36. 1,14 12,252 22.4 PAT margin % 12.1 11.8 15.1 3bps 33bps 1.8 12. 13bps EPS 31.8 32.3 44. 38.3 36. 13.9 127.1 22.4

Exhibit 1: Financial summary Y/E December (Rsmn) CY17 CY17 CY18E CY19E CY2E Net revenues 91,413 1,,96 1,12,492 1,26,835 1,44,563 YoY growth 11.8 9.5 12.4 12.8 14. EBITDA 18,498 2,965 26,244 3,629 35,624 EBITDA margin 2.2 2.9 23.3 24.1 24.6 PAT 1,14 12,252 15,722 18,829 22,473 EPS (Rs) 13.9 127.1 163.1 195.3 233.1 YoY growth 77.8 22.4 28.3 19.8 19.4 RoCE 47. 51.8 62. 65.9 7.5 RoE 31.7 36.6 43.6 47.2 51.1 P/E (x) 58. 61.7 55.1 46. 38.5 P/BV (x) 17.7 22.1 22.9 2.6 18.8 EV/EBITDA (x) 3.3 34.7 31.7 26.8 22.8 Exhibit 2: Our estimates versus actual performance Y/E Dec. (Rsmn) 1QCY17 4QCY17 1QCY18 YoY QoQ NBIE estimate Variation Net sales 24,919 26,15 27,572 1.6 6. 27,99 (1.2) EBITDA 5,174 5,335 6,969 34.7 3.6 6,14 13.5 EBITDA margin 2.8 2.5 25.3 45bps 48bps 22. 33bps Net Income 3,68 3,118 4,24 38.2 36. 3,753 13. Exhibit 3: Change in our estimates Y/E December Old estimate New estimate Change (Rsmn) CY18E CY19E CY2E CY18E CY19E CY2E CY18E CY19E CY2E Net sales 1,12,828 1,27,212-1,12,492 1,26,835 1,44,563 (.3) (.3) N.A. EBITDA 24,625 28,551-26,244 3,629 35,624 6.6 7.3 N.A. EBITDA 21.8 22.4-23.3 24.1 24.6 15bps 17bps N.A. PAT 15,32 18,118-15,722 18,829 22,473 4.6 3.9 N.A. Exhibit 4: Category wise volume growth trend Segment volume growth CY13 CY14 CY15 CY16 CY17 CY18E CY19E CY2E Milk products and Nutrition (1) (2) (3) (2) 2 4 5 5 Prepared dishes and cooking aids 4 4 (59) 71 19 14 12 13 Beverages 9 (11) (1) 11 8 8 8 Chocolate and Confectionaries (2) (12) (19) 7 4 6 6 6 Overall Volume growth 2 (25) 35 11 1 9 1 Exhibit 5: Category wise revenue growth trend Segment revenue growth CY13 CY14 CY15 CY16 CY17 CY18E CY19E CY2E Milk products and Nutrition 5 12 2 1 2 8 8 8 Prepared dishes and cooking aids 11 1 (56) 75 18 18 19 21 Beverages 18 1 (3) 7 12 14 16 Chocolate and Confectionaries 1 (3) (11) 7 3 12 12 12 Overall Revenue growth* 9 8 (17) 13 11 13 13 14 *Comparable sales growth; 2 Nestle India

May-13 Jul-13 Sep-13 Nov-13 Jan-14 Mar-14 May-14 Jul-14 Sep-14 Nov-14 Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Jan-16 Mar-16 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 Jul-17 Sep-17 Nov-17 Jan-18 Mar-18 May-18 Institutional Equities Exhibit 6: Volume driven sales growth Exhibit 7: EBITDA growth coming back (Rsmn) 3, 25, 2, 15, 1, 5, 34.4 15.7 14.8 1.6 9.1 6.8 7.3 3QCY16 4QCY16 1QCY17 2QCY17 3QCY17 4QCY17 1QCY18 Net Sales Growth YoY % 4 35 3 25 2 15 1 5 (Rsmn) 8, 7, 6, 5, 4, 3, 2, 1, 8.7 37.2 34.7 2.8 1.2.9 -.7 3QCY16 4QCY16 1QCY17 2QCY17 3QCY17 4QCY17 1QCY18 EBITDA Growth YoY % 9 8 7 6 5 4 3 2 1 (1) Exhibit 8: Net income growth trend Exhibit 9: Margin trending upwards (Rsmn) 4,5 4, 3,5 3, 2,5 2, 1,5 1, 5 124.2 59.6 38.2 23.3 6.7 6.8 9.7 3QCY16 4QCY16 1QCY17 2QCY17 3QCY17 4QCY17 1QCY18 Net income Growth YoY % 14 12 1 8 6 4 2 26 25 24 23 22 21 2 19 18 17 15.1 13.4 25.3 12.1 23.2 11.7 11.8 1.8 2.6 2.8 2.5 8.5 19.2 3QCY16 4QCY16 17.2 1QCY17 2QCY17 3QCY17 4QCY17 1QCY18 EBITDA margin % Net profit margin % 16 15 14 13 12 11 1 9 8 Exhibit 1: One-year forward P/E (x) 12 1 8 6 4 2 Forward PE 5 yr Median SD +1 SD -1 3 Nestle India

Financials (Standalone) Exhibit 11: Income statement Y/E December (Rsmn) CY16 CY17 CY18E CY19E CY2E Net Sales 91,413 1,,96 1,12,492 1,26,835 1,44,563 % Growth 11.8 9.5 12.4 12.8 14. COGS 38,828 43,269 46,834 52,526 59,613 Staff costs 9,16 1,175 11,349 12,81 14,564 Other expenses 25,71 25,688 28,65 3,869 34,762 Total expenses 72,915 79,131 86,247 96,26 1,8,939 EBITDA 18,498 2,965 26,244 3,629 35,624 % growth 13.5 13.3 25.2 16.7 16.3 EBITDA margin 2.2 2.9 23.3 24.1 24.6 Other income 1,59 1,769 2,281 2,934 3,739 Interest costs 99 919 1,14 965 965 Depreciation 3,537 3,423 3,666 4,24 4,244 Profit before tax (before 15,562 18,393 23,845 28,574 34,153 exceptional items) Exceptional items (18) Tax 5,44 6,141 8,123 9,745 11,68 PAT 1,14 12,252 15,722 18,829 22,473 Adj PAT 1,122 12,252 15,722 18,829 22,473 Adj PAT margin 1.9 12. 13.7 14.5 15.2 % Growth 77.8 22.4 28.3 19.8 19.4 Exhibit 13: Balance sheet Y/E December (Rsmn) CY16 CY17 CY18E CY19E CY2E Share capital 964 964 964 964 964 Reserves 31,859 33,241 36,875 4,981 45,7 Net worth 32,823 34,26 37,839 41,945 46,34 Total debt 332 351 45 57 578 Deferred tax liability 1,553 1,22 1,687 1,93 2,168 Total liabilities 54,437 58,699 63,825 71,498 79,717 Gross block 3,951 33,584 35,584 37,584 39,584 Depreciation 3,532 7,51 1,717 14,741 18,985 Impairment 118 372 372 372 372 Net block 27,31 26,162 24,496 22,472 2,227 Capital work-in-progress 1,882 942 1,2 1,2 1, Investments 17,557 19,789 21,936 24,733 28,19 Inventories 9,41 9,25 9,965 11,98 12,263 Debtors 979 89 959 1,125 1,251 Cash 8,8 14,574 19,329 26,862 35,283 Loans & advances 81 752 797 897 1,21 Other current assets 669 661 675 634 723 Total current assets 32,828 39,374 46,35 57,915 69,334 Creditors 7,992 9,846 9,657 11,641 12,531 Other current liabilities & 5,138 4,26 5,625 6,342 7,228 provisions Total current liabilities 13,668 14,927 16,47 19,251 21,24 Net current assets 19,161 24,447 29,943 38,664 48,13 Total assets 54,437 58,699 63,825 71,498 79,717 Exhibit 12: Cash flow Y/E December (Rsmn) CY16 CY17 CY18E CY19E CY2E PAT 1,14 12,252 15,722 18,829 22,473 Depreciation 3,537 3,423 3,666 4,24 4,244 Other income (1,59) (1,769) (2,281) (2,934) (3,739) (Inc.)/dec. in working capital (177) 1,61 59 748 1,349 Cash flow from operations 11,864 15,516 17,617 2,668 24,327 Capital expenditure (-) (2,7) (2,5) (2,5) (2,5) (2,5) Net cash after capex 9,794 13,16 15,117 18,168 21,827 Dividends paid (-) (5,64) (8,292) (1,219) (12,239) (15,282) DDT paid (-) (1,148) (1,688) (2,75) (2,485) (3,12) Inc./(dec.) in investments (2,75) (463) 134 137 282 Cash from financial activities (3,71) (7,1) (1,81) (11,156) (14,253) Opening cash balance 4,996 8,8 14,574 19,329 26,862 Closing cash balance 8,8 14,574 19,329 26,862 35,283 Change in cash balance 3,85 5,774 4,755 7,533 8,421 Exhibit 14: Key ratios Y/E December (Rsmn) CY16 CY17 CY18E CY19E CY2E Per share (Rs) EPS 13.9 127.1 163.1 195.3 233.1 Book value 34.5 354.8 392.5 435.1 477.5 DPS 58.5 86. 16. 127. 158.5 Valuation (x) P/Sales 6.4 7.6 7.7 6.8 6. EV/sales 6.1 7.3 7.4 6.5 5.6 EV/EBITDA 3.3 34.7 31.7 26.8 22.8 P/E 58. 61.7 55.1 46. 38.5 P/BV 17.7 22.1 22.9 2.6 18.8 Return ratios RoCE 47. 51.8 62. 65.9 7.5 RoE 31.7 36.6 43.6 47.2 51.1 Profitability ratios Gross margin 57.5 56.8 58.4 58.6 58.8 EBITDA margin 2.2 2.9 23.3 24.1 24.6 EBIT margin 16.4 17.5 2.1 21. 21.7 PAT margin 1.8 12. 13.7 14.5 15.2 Liquidity ratios Current ratio 2.4 2.6 2.8 3. 3.3 Quick ratio 1.7 2. 2.2 2.4 2.7 Solvency ratio Debt to Equity ratio - - - - - Turnover ratios Total asset turnover ratio (x) 1.3 1.4 1.4 1.4 1.4 Fixed asset turnover ratio (x) 3.3 3.8 4.6 5.6 7.1 Inventory days 83 78 74 76 74 Debtors days 4 3 3 3 3 Creditor days 73 75 76 74 74 4 Nestle India

Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Institutional Equities Rating track Date Rating Market price (Rs) Target price (Rs) 13 March 218 Buy 7,619 9,4 11 May 218 Buy 8,981 1,7 Rating track graph 1, 9,5 9, 8,5 8, 7,5 7, 6,5 6, 5,5 5, Not Covered Covered 5 Nestle India

DISCLOSURES This Report is published by Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) for private circulation. NBEPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 214 having Registration no. INH1436. NBEPL is also a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. NBEPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. NBEPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. NBEPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBEPL or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. NBEPL or its associates or Analyst or his relatives do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. NBEPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. NBEPL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of Subject Company and NBEPL / analyst has not been engaged in market making activity of the subject company. Analyst Certification: I/We, Mr. Vijay Chugh independent research Analyst and Abhishek Navalgund the research Associate, are the authors of this report, hereby certify that the views expressed in this research report accurately reflects my/our personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst(s) principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 6 Nestle India

Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. NBEPL is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of NBEPL and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. NBEPL will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject NBEPL & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. NBEPL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NBEPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. NBEPL reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBEPL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of NBEPL accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither NBEPL, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with NBEPL. Our reports are also available on our website www.nirmalbang.com Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Email Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com +91 22 6273 817 / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com +91 22 6273 823, +91 22 6636 8833 Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com +91 22 6273 81/811, +91 22 6636 8831 Michael Pillai Dealing Desk michael.pillai@nirmalbang.com +91 22 6273 812/813, +91 22 6636 883 Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 31/32, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai-413. Board No. : 91 22 3926 8/1; Fax. : 22 3926 81 7 Nestle India